Baltimore, MD – According to filings with the U.S. Securities and Exchange Commission, LifeSprout is raising $26,195,249.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Eric Goorno played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About LifeSprout
LifeSprout, Inc. is a privately held company developing revolutionary products for aesthetic and regenerative medicine. The companys Regenerative Matrix platform leverages advances in materials science to create products that look and feel like the bodys own tissues. LifeSprout is turning this technology into a suite of products for the millions of patients with tissue losses from aging, cancer, metabolic disease, and orphan indications. The companys lead product Lumina is a breakthrough family of aesthetic fillers enabling immediate, natural restoration with biostimulatory effects. LifeSprouts next generation cell therapy products use the power of the platform to promote true tissue regeneration.

To learn more about LifeSprout, visit http://www.lifesproutbio.com/

Contact:
Eric Goorno, Chief Executive Officer
410-800-0740
egoorno@lifesproutbio.com
https://www.linkedin.com/in/eric-goorno-6973b87/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved